comparemela.com

Latest Breaking News On - Ocular immunology - Page 1 : comparemela.com

Roivant Sciences : NIU Phase 2 Topline Results -April 02, 2024 at 08:48 am EDT

NIU Phase 2 Topline Results and Corporate Updates April 2024 Forward-Looking Statements Forward-Looking Statements .

United-states
Roivant-priovant
Demyelinating-polyneuropathy-immunovant
Dermatomyositis-priovant
Gravis-immunovant
Exchange-commission
Capital-allocation
Positive-results
Share-repurchase-program-including-purchase
Entire-sumitomo-stake
Reducing-share-count
Next-chapter

Pearce IP BioBlast w/e 8 March 2024

On 9 March 2024, Samsung Bioepis presented two papers of study results for its immunology portfolio at the 2024 American Academy of Dermatology (AAD)…

Australia
United-states
France
India
United-kingdom
China
California
Virginia
Canada
Switzerland
San-diego
American

Gout Therapeutics Market to be Worth $4.13 Billion by 2030: Grand View Research, Inc.

/PRNewswire/ The global gout therapeutics market size is expected to reach USD 4.13 billion by 2030 and expand at a CAGR of 6.25% from 2023 to 2030,.

United-states
France
Argentina
Kuwait
California
Canada
Mexico
Germany
San-francisco
Australia
Saudi-arabia
Thailand

SightMD Connecticut Welcomes Shimy Apoorva, DO to its expert team

Hauppauge, NY (PRWEB) July 17, 2023 SightMD Connecticut, a leading multi-specialty ophthalmology platform in Connecticut, welcomes Shimy Apoorva, DO to

Connecticut
United-states
New-york
Hauppauge
Georgia
Philadelphia
Pennsylvania
American
Stephenc-foster
Shimy-apoorva
Fichman-eye-center
American-osteopathic-association

Prevalence and Risk Factors of Dry Eye Disease

Laura Periman, MD, discusses the prevalence and risk factors of dry eye disease.

Laura-periman
Dry-eye-disease
Risk-factors
Dry-eye
Ocular-surface
Cornea
Chronic-surface-disease
Blurry-vision
Sustaining
Fluctuations
Vision

vimarsana © 2020. All Rights Reserved.